Search - tctmd.com

Displaying 21 - 40 of 734

Sort: Relevancy | Date

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Daily News

CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs

Todd Neale

November 27, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF

Yael L. Maxwell

November 25, 2024

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Daily News

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

Todd Neale

November 25, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News AHA 2024

Infections No More Likely With Reconditioned Versus New Pacemakers

Yael L. Maxwell

November 22, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

Talking Sex: CVD Patients Want to Hear More From Clinicians

Caitlin E. Cox

November 20, 2024

News Conference News AHA 2024

AI Poised to Change the Landscape of Echocardiography

Yael L. Maxwell

November 19, 2024

Presentation AHA 2024

Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations

Presenter: Daniel Bensimhon

November 18, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News AHA 2024

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

Caitlin E. Cox

November 18, 2024

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

Advertisement

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

TCTMD’s Top 10 Most Popular Stories for November 2024

CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

November 2024 Dispatch for the CV Team

Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

Infections No More Likely With Reconditioned Versus New Pacemakers

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Talking Sex: CVD Patients Want to Hear More From Clinicians

AI Poised to Change the Landscape of Echocardiography

Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content